Erika Sales Lopes

Erika Sales Lopes

Auto-generated profile, based on publicly available information

Erika Sales Lopes

Universidade Federal do Maranhão, Grupo de Pesquisa Clínica e Molecular em Endocrinologia e Metabologia, São Luís, MA, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
GPGabriella Nascimento Pinto
Gabriella Nascimento Pinto
AMAna Caroline Santa Rosa Malcher
Ana Caroline Santa Rosa Malcher
CSCarol Do Carmo e Silva
Carol Do Carmo e Silva
GLGércia Samilles Almeida Lira
Gércia Samilles Almeida Lira
CACélia Regina de Araújo Do Amaral
Célia Regina de Araújo Do Amaral
CMClaudia Marques Santa Rosa Malcher
Claudia Marques Santa Rosa Malcher
Introduction: Studies have described clinical characteristics of individuals with coronavirus disease (COVID-19). However, there are still few data on the clinical characteristics in the post-covid period. Objective: to describe the clinical and epidemiological characteristics of 267 individuals in the Amazon in the post-covid period. Methods: This is an observational epidemiological study, with a cross-sectional design, guided by the STROBE tool. Where we retrospectively interviewed adults who had laboratory-confirmed COVID-19 infection seen at the Primary Health Care (PHC) of the Municipality of Cachoeira do Piriá, during the COVID-19 pandemic from January to February 2021. Sociodemographic data, clinical history and care, comorbidities, and treatment were recorded for each of the 267 individuals over 18 years of age. Results: Females were predominant in 61.7% (n=165). Individuals reported as coexisting risk medical conditions, hypertension as the most common comorbidity in 14.6% (n=39). In this study, 57% (n=152) of people reported tiredness/fatigue as the main symptom that persisted for more than 3 months. Fever was the most reported first sign in 25.3% (n=67). Conclusions: There is a need for multidisciplinary follow-up to support PHC.

27 October 2026 in Brazilian Dental Science
Verified
Journal Article
Open access
PDF file
JRJessilene Ribeiro Rocha
Jessilene Ribeiro Rocha
MAMila Lima Assunção
Mila Lima Assunção
TPTalita Raquel Almeida Portella
Talita Raquel Almeida Portella
ELErika Sales Lopes
Erika Sales Lopes
GNGilvan Cortês Nascimento
Gilvan Cortês Nascimento
Vandilson RodriguesVandilson Rodrigues
Vandilson Rodrigues
Objective: To investigate salivary pro- and anti-inflammatory cytokine profiles in adults with type 2 diabetes (T2D) and their associations with glycaemic markers. Material and Methods: A cross-sectional study was conducted including 20 adults with T2D and 20 age-matched controls. Unstimulated saliva was collected, and concentrations of IL-1β, IL-4, IL-6, IL-8, IL-10, IL-17A, IL-22, TGF-α, and TNF-α were quantified using a multiplex immunoassay. Fasting blood glucose (FBG) and glycated haemoglobin (HbA1c) were obtained from clinical records. Results: T2D group exhibited higher salivary IL-6 and IL-10 levels compared with controls. Several pro-/anti-inflammatory cytokine ratios, including IL-1β/IL-10, IL-8/IL-10, TGF-α/IL-10, and TNF-α/IL-10, were significantly altered in the T2D group. In the T2D group, IL-1β, IL-6, IL-10, IL-22, TGF-α, and TNF-α were positively correlated with FBG, whereas specific ratios, such as IL-22/IL-4 and TNF-α/IL-4, were positively associated with HbA1c. Conclusion: Adults with T2D display a distinct salivary cytokine profile characterised by elevated IL-6 and IL-10 and altered pro-/anti-inflammatory ratios. Salivary cytokine levels are associated with both short- and long-term glycaemic control, suggesting that salivary biomarkers can reflect systemic metabolic and inflammatory status.